Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuBase Therapeutics Inc.

0.3780
+0.0000
Volume:- -
Turnover:- -
Market Cap:1.42M
PE:-0.03
High:0.3780
Open:0.3780
Low:0.3780
Close:0.3780
Loading ...
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jun 27, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jun 27, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jun 27, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jun 27, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 22, 2024

Major Issues Report

Form 8-K - Current report
May 16, 2024

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
May 13, 2024

Major Issues Report

Form 8-K - Current report
May 03, 2024

Major Issues Report

Form 8-K - Current report
Apr 05, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 23, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 26, 2024

Major Issues Report

Form 8-K - Current report
Jan 17, 2024

Major Issues Report

Form 8-K - Current report
Dec 28, 2023

Major Issues Report

Form 8-K - Current report
Dec 22, 2023

Major Issues Report

Form 8-K - Current report